# PubMed record PMID 42495930

> PeptideScanner retained PubMed bibliographic metadata for PMID 42495930 at 2026-08-10T10:49:10.785Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42495930-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-06
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42495930-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42495930-semaglutide-v1.json
- Content SHA-256: `0e01bc15dc2a8b2a84f4526d52d63933ddf8fae1976f5634cac78fabd26ecb79`

## Claims and source pins

### Headline

PubMed record PMID 42495930 ([`pubmed-observation-pmid-42495930-2026-08-06-12fbcd51f647`](#source-pubmed-observation-pmid-42495930-2026-08-06-12fbcd51f647))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42495930 at 2026-08-10T10:49:10.785Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42495930-2026-08-06-12fbcd51f647`](#source-pubmed-observation-pmid-42495930-2026-08-06-12fbcd51f647))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42495930 at 2026-08-10T10:49:10.785Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42495930-2026-08-06-12fbcd51f647`](#source-pubmed-observation-pmid-42495930-2026-08-06-12fbcd51f647))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42495930-2026-08-06-12fbcd51f647`](#source-pubmed-observation-pmid-42495930-2026-08-06-12fbcd51f647))

## Sources

<a id="source-pubmed-observation-pmid-42495930-2026-08-06-12fbcd51f647"></a>
- **PubMed record PMID 42495930 · retained source version 1:2026-08-06:current:12fbcd51f6478058bafd79bc74a677f4a2fbc87e85002f59afd1dd02c8d139ba** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42495930/) (`pubmed-observation-pmid-42495930-2026-08-06-12fbcd51f647`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 42495930." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42495930-semaglutide-v1.json SHA-256: 0e01bc15dc2a8b2a84f4526d52d63933ddf8fae1976f5634cac78fabd26ecb79.